Oaktree Ends Atlantic Coast Life Takeover Plan as A-Cap Talks Continue

Oaktree’s control plan is off the table

Oaktree Capital Management has abandoned its plan to take control of Atlantic Coast Life Insurance, leaving the insurer’s owner, Advantage Capital Holdings (A-Cap), to seek a transaction structure acceptable to South Carolina regulators. The March agreement is no longer proceeding, though Oaktree and A-Cap remain in discussions, according to people familiar with the private talks. That distinction matters: the original route to a deal has ended, but the parties haven’t publicly closed the door on working together.

“We are continuing to work constructively with Oaktree on a transaction structure that will meet the approval of the South Carolina Department of Insurance,” an A-Cap spokesperson said. Brookfield Asset Management, Oaktree’s owner, declined to comment. The South Carolina Department of Insurance also declined to comment. Those limited statements leave key questions unanswered, including what a revised structure might involve and whether it would address regulators’ concerns.

For Oaktree, a firm focused on distressed companies, the change puts the emphasis on negotiating terms within regulatory constraints. A transaction that shifts control or provides capital can have a different effect on an insurer depending on its details; the source gives no terms for the abandoned agreement or any replacement proposal. For now, the talks are evidence of continued engagement, not evidence that an acceptable deal is close.

Regulatory scrutiny clouds a potential transaction

The setback comes as Atlantic Coast and its subsidiary Southern Atlantic Re face questions about lending to 777 Partners, the now-defunct investment firm. Creditors have alleged that 777 borrowed against assets that were nonexistent or already pledged elsewhere. Federal prosecutors accused 777 co-founder Josh Wander last year of defrauding lenders and investors of nearly $500 million. He pleaded guilty this week to wire fraud and securities fraud and faces sentencing in March.

The 777 matter raises a basic question for insurers and their overseers: what assets support the companies’ financial position, and how clearly have related exposures been disclosed? The allegations concern 777 and its dealings; they don’t, by themselves, establish that the insurers committed wrongdoing. But when an insurer has financial ties to a troubled borrower, regulators and policyholders have reason to scrutinize the value, documentation, and concentration of those exposures.

South Carolina insurance officials have challenged the insurers’ financial position and disclosures. In a petition seeking their rehabilitation, Insurance Department Director Michael Wise described the companies as being in a “financially hazardous” position, alleging that they overstated some asset values and did not fully disclose certain affiliate investments. Rehabilitation is an emergency process intended to restore an insurer’s finances. The allegations are serious, but they remain the department’s claims in a petition; the available account doesn’t describe a final resolution of them.

The dispute follows earlier regulatory action. South Carolina sought to stop Atlantic Coast from selling annuities in 2024, but a judge overturned that move in 2025. Utah regulators entered mediation with other A-Cap insurance operations. In late September, Florida’s insurance commissioner suspended Atlantic Coast Life, citing concerns that included its declining surplus.

These actions come from different states and involve distinct steps, so they shouldn’t be treated as a single ruling. Taken together, though, they show why a prospective owner would have to weigh more than the purchase terms. The company’s ability to operate, the condition of its capital, and the handling of regulator concerns all bear on whether a transaction can proceed.

Ratings and capital questions remain

The companies filed a complaint against Wise in his official and personal capacities, then dismissed the lawsuit and agreed to mediation. A-Cap insurers have said they continue to honor policyholder contracts. That statement speaks to current performance of those contracts, but it doesn’t settle the separate questions regulators and ratings analysts have raised about balance sheet strength, disclosures, or future financial capacity.

AM Best downgraded Atlantic Coast Life and Sentinel Security Life Insurance Co. last month. The ratings firm cited “increasing weakness in A-Cap Group’s balance sheet strength as well as its operating performance during the first half of 2026.” A-Cap disputed the downgrade, saying it didn’t account for efforts to strengthen capital and restructure.

A downgrade is a signal about an insurer’s assessed financial condition, not a direct account of whether a particular policyholder claim will be paid. Still, ratings matter because they can shape how counterparties and customers assess an insurer’s capacity to meet obligations. The disagreement between AM Best and A-Cap also points to a gap in interpretation: the rating firm emphasized reported weakness, while the group says its corrective efforts deserve more weight.

The numbers here are underwhelming as a basis for confidence: the available account offers no detail on the size or timing of A-Cap’s capital efforts. That doesn’t mean those efforts have failed. It does mean outside readers can’t judge their effect from the company’s statement alone.

What a revised deal would need to address

For Oaktree, which focuses on distressed companies, the original control transaction has given way to negotiations under heightened regulatory and financial scrutiny. Any alternative structure will need to address the concerns South Carolina officials have raised. The talks may continue, but their practical value will depend on whether they produce a proposal regulators can assess against the insurers’ financial condition and disclosures.

This is more significant than it looks. A change in deal structure can alter who supplies capital, who exercises control, and how responsibilities are divided, though no such details have been reported here. In insurance, those questions connect directly to the ability to support policy obligations. And this is the part most people overlook: agreement between a buyer and an owner wouldn’t, on its own, resolve the regulator’s concerns.

If you’re working in this space, the useful distinction is between a continuing discussion and a credible path to approval. A-Cap says it’s working with Oaktree, while regulators have raised questions about assets, affiliate investments, and financial condition. Until the parties disclose more about a proposed structure, the central issue remains unresolved. A deal in discussion. Not yet a solution.

That said, the end of the March agreement doesn’t establish that no transaction can be reached. It shows that the original plan isn’t proceeding in its existing form. The next meaningful development would be evidence of a revised proposal and how it responds to the issues already raised; without that, the market and policyholders are left with competing statements and an open process.